Dr.Sharon Dougall, Phd in Social Work, hepatitis C outreach coordinator in Chicago, Illinois. Advocate of healthcare access and medical tourism, approved article.
Sunny Pharma is founded by American families, physicians and non profits to promote access to treatment and healthcare that is safe and affordable for all.
Hepatitis C Treatment Cost in India
If you did not know, yes hepatitis C treatment cost in India is very affordable.
And generic Sovaldi, sofosbuvir is $694 for 84 tablets, 12 weeks treatment.
Most hepatitis C treatment cost in India is about $777 or less.
This cost savings have helped 1000’s of Americans and everyone else around the world save lives.
Only exceptions are generics of Mavyret (glecaprevir and pibrentasvir) and Vosevi (voxilaprevir, velpatasvir and sofosbuvir).
Generic Mavyret and generic Vosevi are both $9520 for the average treatment course.
Mavyret price in India is more expensive because it has to be made to order.
Same goes with Vosevi price in India, once we receive an order we have our compounding pharmacists get the API and make it.
Its a lot more expensive at the same time more affordable than $24,000 in the US or elsewhere.
With insurance (in the US) you will pay a lot more for hep C meds, anywhere between $10,000 to $15,000.
That is if you are one of the lucky people that get approved for the new generation of hepatitis C meds.
Stop paying more hep C treatment.
Hepatitis C treatment cost in India is ONLY $777.
Why the big price difference?
Let’s think about it.
We all know India is comparably poor in many ways to the US. That’s the first thing.
Second, the cost of labor is a lot less.
Indian rupee is very low in value compared to the US dollar.
The average income per person is about $800. Compare that to the average person making $55,000 income in the US.
When it comes to medicine and hepatitis C treatment in India, its a lot less.
For example the active pharmaceutical ingredient or API to make hepatitis C medicine is about $5 for 2 pounds. Two pounds of the active ingredient can cure 25 patients with hepatitis C.
That is amazing!
Yes, Gilead spent $11.2 billion dollars in buying the company that invented the medicine, so they charge us an arm and a leg when the treatment first came out in 2014.
Since then we have helped 1000’s access hepatitis C meds for a fraction of the price in the US or any developed country.
All hepatitis C treatments from India are licensed by Gilead and manufacturing facilities are audited by the FDA.
Every time you buy a generic Harvoni, generic Epclusa velpatasvir-sofosbuvir, generic Sovaldi sofosbuvir or any Gilead’s hepatitis C treatment from India, up to 50% of the cost is paid to Gilead Sciences in royalty fees.
Want to talk to a health care advocate about hepatitis C treatment cost in India?
Sunny Pharma USA:
Address: 6251 La Jolla Scenic Dr S, La Jolla, California, USA 92037
Email us at [email protected] or just fill the form or click on the bubble below and we’ll reply back right away.
Sunny Pharma India
No 1, 3rd G Main, Old Nilgiris Road Rammaiah Layout, 3rd E-F Cross Rd, Ramaiah Layout, Kacharakanahalli, Bengaluru, Karnataka 560084